FPMAJ States Difficulty in Identifying Anticancer Drugs in Terms of Adverse Reactions

October 4, 2011
Takashi Shoda, chairman of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), called for careful consideration in establishing a relief system for victims with adverse reactions caused by anticancer drugs, saying that there is difficulty in identifying anticancer drugs...read more